Summary
Updated Aug 31, 2026
Catherine Moukheibir is Director of MoonLake Immunotherapeutics (MLTX). 3 SEC Form 4 filings on record going back to 2025, most recently on 18 June 2026. Most recent open-market trade: sold $1.15M of MLTX on 3 July 2025. Lifetime open-market sales: $1.15M.
Recent Transactions
3Every recent SEC Form 4 transaction Catherine Moukheibir has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Catherine Moukheibir go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Catherine Moukheibir files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $62.96M of MLTX open-market activity in the last 12 months
- Bihua Chen - $46.87M of MLTX open-market activity in the last 12 months
- Alexander J. Denner - $20.53M of IRWD open-market activity in the last 12 months
- da Silva Jorge Santos - $8.73M of MLTX open-market activity in the last 12 months
- Kristian Reich - $8.14M of MLTX open-market activity in the last 12 months
- Matthias Bodenstedt - $3.30M of MLTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Catherine Moukheibir?
Catherine Moukheibir is a corporate insider, tracked as Director of MoonLake Immunotherapeutics (MLTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Catherine Moukheibir submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Catherine Moukheibir been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.15M) across all tracked filings.
Where can I see all of Catherine Moukheibir's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Catherine Moukheibir and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial